生体認証はマラリア対策にどう役立つのか
マラリア・ワクチンの配布と追跡に生体認証ソリューションを初めて導入したこの画期的な取り組みは、多くの命を救う可能性を秘めています。どのように機能し、なぜ今それが重要なのでしょうか。
Toby Norman is the Chief Executive Officer of Simprints Technology, a Cambridge-based nonprofit technology startup that builds biometrics for beneficiary identification in developing countries. He is passionate about bringing cutting-edge technology to solve challenges in global health and international development. He holds a PhD in Management from the University of Cambridge, where he was a Gates Scholar, and BA in Biology from Harvard University. Toby brings ten years of experience with international field projects, operations management, and non-profit work in collaboration with Harvard. He has been recognised as a Forbes 30 Under 30 Social Entrepreneur, TechCrunch: Best Tech leader, a 2017 Schwab Social Entrepreneur of the Year Awardee, and most recently, a 2018 GLG Social Impact Fellow.
マラリア・ワクチンの配布と追跡に生体認証ソリューションを初めて導入したこの画期的な取り組みは、多くの命を救う可能性を秘めています。どのように機能し、なぜ今それが重要なのでしょうか。
For the first time in history, a biometric solution will be applied to track and trace the delivery of malaria vaccines, helping to save lives. How does it work and why is it important now?